SMAD7 anticorps (AA 88-135)
Aperçu rapide pour SMAD7 anticorps (AA 88-135) (ABIN7877026)
Antigène
Voir toutes SMAD7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 88-135
-
Fonction
- MADH7 Antibody / SMAD7
-
Purification
- Antigen affinity purified
-
Immunogène
- Recombinant human protein (amino acids A88-R135) was used as the immunogen for the MADH7 antibody.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal dilution of the MADH7 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- After reconstitution, the MADH7 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- SMAD7 (SMAD, Mothers Against DPP Homolog 7 (SMAD7))
-
Autre désignation
- MADH7
-
Sujet
- Mothers against decapentaplegic homolog 7 or SMAD7 is a protein that in humans is encoded by the SMAD7 gene. The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene.
-
UniProt
- O15105
-
Pathways
- Interferon-gamma Pathway, Cell-Cell Junction Organization
Antigène
-